Medicxi Growth I LP 13D and 13G filings for Phathom Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-26 4:00 pm Purchase | 2024-01-24 | 13G | Phathom Pharmaceuticals, Inc. PHAT | Medicxi Growth I LP | 7,464,572 13.000% | 4,980,298 (+200.47%) | Filing |
| 2023-01-31 4:00 pm Purchase | 2022-12-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT | Medicxi Growth I LP | 2,484,274 6.000% | 416,413 (+20.14%) | Filing |